Glover Stephen C.
SEC insider (Form 3/4/5 filer). CIK 0001304406. Director at ONCOLYTICS BIOTECH INC (ONCY) and 2 other issuers. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in SAN DIEGO, CA.
Companies Glover Stephen C. has filed insider reports for
- ONCOLYTICS BIOTECH INC (ONCY): Director
- PDS Biotechnology Corp (PDSB): Director
- ZyVersa Therapeutics, Inc. (ZVSA): Director, Officer, Chief Executive Officer
Glover Stephen C.
CIK: 0001304406
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 1, 2026ONCY
ONCOLYTICS BIOTECH INC
AwardDirectStock Option
96K shares- - Jan 12, 2026PDSB
PDS Biotechnology Corp
AwardDirectEmployee Stock Option (Right to Buy)
54.9K shares- - Jul 11, 2025ZVSA
ZyVersa Therapeutics, Inc.
AwardDirectStock Options
136.9K shares- - Jun 11, 2025PDSB
PDS Biotechnology Corp
AwardDirectEmployee Stock Option (Right to Buy)
22.7K shares- - Feb 28, 2025PDSB
PDS Biotechnology Corp
PurchaseDirect15.1K shares at avg. $1.66$25K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 1, 2026 |  ONCY ONCOLYTICS BIOTECH INC | Award Stock Option | 96,000 | - | - | Direct |
| Jan 12, 2026 |  PDSB PDS Biotechnology Corp | Award Employee Stock Option (Right to Buy) | 54,876 | - | - | Direct |
| Jul 11, 2025 |  ZVSA ZyVersa Therapeutics, Inc. | Award Stock Options | 136,900 | - | - | Direct |
| Jun 11, 2025 | PDSB PDS Biotechnology Corp | Award Employee Stock Option (Right to Buy) | 22,700 | - | - | Direct |
| Feb 28, 2025 | PDSB PDS Biotechnology Corp | Purchase | 15,061 | $1.66 | $25,001 | Direct |
1-5 of 5 transactions